NDC 0071-1018 – Lyrica
Pregabalin 300 mg/1 · Capsule · Oral
Product NDC0071-1018
Product details
- Brand name
- Lyrica
- Generic name
- Pregabalin
- Labeler
- Parke-Davis Div of Pfizer Inc
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA021446
- Marketed since
- December 30, 2004
- Marketing end
- December 31, 2026
Active ingredients
- Pregabalin 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0071-1018-68 | 90 CAPSULE in 1 BOTTLE (0071-1018-68) | Dec 30, 2004 |
Recalls mentioning this NDC
- D-0648-2016 Feb 10, 2016 · Class II
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules. - D-0649-2016 Feb 10, 2016 · Class II
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Other Lyrica products
- 58151-236 Pregabalin 25 mg/1 · Capsule · Viatris Specialty LLC
- 58151-237 Pregabalin 50 mg/1 · Capsule · Viatris Specialty LLC
- 58151-238 Pregabalin 75 mg/1 · Capsule · Viatris Specialty LLC
- 58151-239 Pregabalin 100 mg/1 · Capsule · Viatris Specialty LLC
- 58151-240 Pregabalin 150 mg/1 · Capsule · Viatris Specialty LLC
- 58151-241 Pregabalin 200 mg/1 · Capsule · Viatris Specialty LLC
- 58151-242 Pregabalin 300 mg/1 · Capsule · Viatris Specialty LLC
- 58151-243 Pregabalin 225 mg/1 · Capsule · Viatris Specialty LLC
- 58151-244 Pregabalin 20 mg/mL · Solution · Viatris Specialty LLC